Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Executive Partner, Sofinnova Ventures
Founder and Managing Director of DEV
Founder and CEO of Brooks Bell Inc.
|Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial||David Holley||03/12/15||San Francisco|
|Allergen Research Corporation Obtains $17,000,000 New Funding||VentureDeal||11/22/13||San Francisco|
|Page 1 of 1|